documents: FDA-1994-E-0047-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1994-E-0047-0001 FDA FDA-1994-E-0047 Determination of Regulatory Review Period for Purposes of Patent Extension; Risperdal® Notice General Notice 1994-10-27T04:00:00Z 1994 10 1994-10-27T04:00:00Z 1994-11-01T04:59:59Z 2024-05-23T16:08:19Z   0 0 09000064804ff746

Links from other tables